Markku Taskinen
Laboratory Engineer
Tasks include (at the school of Pharmacy) the management of teaching and research equipment, the premises, controlled substances and the tasks related to occupational safety and health > Ask if you need help
School of Pharmacy, Faculty of Health Sciences
markku.taskinen@uef.fi | +358 40 355 2475
Employee can call me, if he/she need
- help with any equipment (or can not find one) (purchase-maintenance-removal/disposal)
- a room, laboratory or change on those
- some controlled substances for research
- solve in any other problem
Publications
7/7 items-
Teknisen työn kehitys ja muutokset farmasialla
Taskinen Markku, Hänninen Pirjo, Jaatinen Hannele, Rissanen Helly, Pitkänen Kaarina, Roivainen Anne, Ukkonen Sari, Pirskanen Lea. Teoksessa: Ahonen R, Laitinen K, Lapinjoki S, Mensalo P, Ranta V-P, Ylikangas H (toim).(toim.) , 2013. Muutosten vuosikymmen : Itä-Suomen yliopiston farmasian laitos 40 vuotta. s. 59-62. -
Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells
Räikkönen Johanna, Taskinen Markku, Dunford James E, Mönkkönen Hannu, Auriola Seppo, Mönkkönen Jukka. 2011. Biochemical and biophysical research communications. 407: 663-667 -
Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram
Pajula K, Taskinen M, Lehto V-P, Ketolainen J & Korhonen O. 2010. Molecular pharmaceutics. 7: 795-804 -
Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro
Töyräs A, Ollikainen J, Taskinen M, Mönkkönen J. 2003. European journal of pharmaceutical sciences. 19: 223-230 -
Nitrogen-containing bisphosphonates induce apoptosis of caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity
Suri S, Mönkkönen J, Taskinen M, Pesonen J, Blank MA, Phipps RJ, Rogers MJ. 2001. Bone. 29: 336-343 -
Studies on liposome formulations for intra-articular delivery of clodronate
Mönkkönen J, Liukkonen J, Taskinen M, Heath TD, Urtti A. 1995. Journal of controlled release. 35: 145-154 -
The growth inhibition of macrophage like and other cell types by liposome-encapsulated, calcium bound, and free bishosphonates in vitro
Mönkkönen J, Taskinen M, Auriola S, Urtti A. 1994. Journal of drug targeting. 2: 299-308